Transcriptional regulation of vascular endothelial growth factor in cancer

Cytokine and Growth Factor Reviews

Volumn 16, Issue 1, 2005, Pages 77-89

  Loureiro, Robyn M B ^a,b   D'Amore, Patricia A ^a,c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Anti angiogenesis; Growth factors; Tumors; Vascularization; VEGF

Indexed keywords

ACTIVIN A; CYTOKINE; ENDOTHELIAL CELL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; ESTROGEN; FIBROBLAST GROWTH FACTOR 4; GESTAGEN; GONADOTROPIN; GROWTH FACTOR; HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEU DIFFERENTIATION FACTOR; ONCOPROTEIN; PROTEIN P53; PROTEIN P73; RAS PROTEIN; SCATTER FACTOR; SOMATOMEDIN; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VON HIPPEL LINDAU PROTEIN; WNT PROTEIN;

ANGIOGENESIS; CANCER GENETICS; CARCINOGENESIS; HUMAN; HYPOXIA; MOLECULAR BIOLOGY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; TUMOR CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

EID: 14044271973     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2005.01.005     Document Type: Review

References (164)

1. G. Thurston, and N.W. Gale Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis Int J Hematol 80 2004 7 20
2. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669 676
3. N. Ferrara, K. Carver-Moore, H. Chen, M. Dowd, L. Lu, and K. O'Shea Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 380 1996 439 442
4. P. Carmeliet, V. Ferriera, G. Breier, S. Pollefeyt, L. Kieckens, and M. Gertsenstein Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 1996 435 439
5. L. Miquerol, B.L. Langille, and A. Nagy Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression Development 127 2000 3941 3946
6. K.G. Peters, K.C. De Vries, and K.L.T. Williams Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth Proc Natl Acad Sci USA 90 1993 8915 8919
7. W.T. Monacci, M.J. Merrill, and E.H. Oldfield Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues Am J Physiol 264 1993 C995 C1002
8. D.J. Dumont, G.H. Fong, M.C. Puri, G. Gradwohl, K. Alitalo, and M.L. Breitman Vascularization of the mouse embryo: a study of flk-1, tek, tie and vascular endothelial growth factor expression during development Dev Dyn 203 1995 80 92
9. G. Breier, U. Albrecht, S. Sterrer, and W. Risau Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation Development 114 1992 521 532
10. L. Miquerol, M. Gertsenstein, K. Harpal, J. Rossant, and A. Nagy Multiple developmental roles of VEGF suggested by a LacZ-tagged allele Dev Biol 212 1999 307 322
11. D. Shweiki, A. Itin, G. Neufeld, H. Gitay-Goren, and E. Keshet Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis J Clin Invest 91 1993 2235 2243
12. N. Ferrara, H. Chen, T. Davis-Smyth, H.P. Gerber, T.N. Nguyen, and D. Peers Vascular endothelial growth factor is essential for corpus luteum angiogenesis Nat Med 4 1998 336 340
13. F. Shalaby, J. Rossant, T.P. Yamaguchi, M. Gertsenstein, X.-F. Wu, and M.L. Breitman Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 376 1995 62 66
14. G.-H. Fong, J. Rossant, M. Gertsenstein, and M.L. Breitman Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium Nature 376 1995 66 70
15. T. Kawasaki, T. Kitsukawa, Y. Bekku, Y. Matsuda, M. Sanbo, and T. Yagi A requirement for neuropilin-1 in embryonic vessel formation Development 126 1999 4895 4902
16. J. Waltenberger, L. Claesson-Welsh, A. Siegbahn, M. Shibuya, and C.H. Heldin Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor J Biol Chem 269 1994 26988 26995
17. M. Clauss, H. Weich, G. Breier, U. Knies, W. Rockl, and J. Waltenberger The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis J Biol Chem 271 1996 17629 17634
18. G. Neufeld, T. Cohen, H. Gitay-Goren, Z. Poltorak, S. Tessler, and R. Sharon Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants Cancer Metastasis Rev 15 1996 153 158
19. G.T.C. Neufeld, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 1999 9 22
20. S. Hiratsuka, O. Minowa, J. Kuno, T. Noda, and M. Shibuya Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice Proc Natl Acad Sci USA 95 1998 9349 9354
21. S. Soker, S. Takashima, H.Q. Miao, G. Neufeld, and M. Klagsbrun Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor Cell 92 1998 735 745
22. I. Zachary, and G. Gliki Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family Cardiovasc Res 49 2001 568 581
23. S.V. Lutsenko, S.M. Kiselev, and S.E. Severin Molecular mechanisms of tumor angiogenesis Biochemistry (Moscow) 68 2003 286 300
24. S. Morikawa, P. Baluk, T. Kaidoh, A. Haskell, R.K. Jain, and D.M. McDonald Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors Am J Pathol 160 2002 985 1000
25. L. Holmgren, M.S. O'Reilly, and J. Folkman Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat Med 1 1995 149 153
26. A. Pettersson, J.A. Nagy, L.F. Brown, C. Sundberg, E. Morgan, and S. Jungles Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor Lab Invest 80 2000 99 115
27. A. Bikfalvi, and R. Bicknell Recent advances in angiogenesis, anti-angiogenesis and vascular targeting Trends Pharmacol Sci 23 2002 576 582
28. M. Inoue, J.H. Hager, N. Ferrara, H.P. Gerber, and D. Hanahan VEGF-A has a critical, non-redundant role in angiogenic switching and pancreatic beta cell carcinogenesis Cancer Cell 1 2002 193 202
29. H.T. Zhang, P.A. Scott, L. Morbidelli, S. Peak, J. Moore, and H. Turley The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo Br J Cancer 83 2000 63 68
30. J. Grunstein, J.J. Masbad, R. Hickey, F. Giordano, and R.S. Johnson Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature Mol Cell Biol 20 2000 7282 7291
31. J. Hasan, R. Byers, and G.C. Jayson Intra-tumoural microvessel density in human solid tumours Br J Cancer 86 2002 1566 1577
32. T. Lantzsch, L. Hefler, U. Krause, A. Kehl, C. Goepel, and H. Koelbl The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer Anticancer Res 22 2002 1925 1928
33. P. Salven, V. Perhoniemi, H. Tykka, H. Maenpaa, and H. Joensuu Serum VEGF levels in women with a benign breast tumor or breast cancer Breast Cancer Res Treat 53 1999 161 166
34. J. Adams, P.J. Carder, S. Downey, M.A. Forbes, K. MacLennan, and V. Allgar Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen Cancer Res 60 2000 2898 2905
35. H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol 20 2002 4368 4380
36. R. Dittadi, S. Meo, F. Fabris, G. Gasparini, D. Contri, and M. Medici Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments Int J Biol Markers 16 2001 87 96
37. W. Jelkmann Pitfalls in the measurement of circulating vascular endothelial growth factor Clin Chem 47 2001 617 623
38. G. Gasparini Prognostic value of vascular endothelial growth factor in breast cancer Oncologist 5 Suppl. 1 2000 37 44
39. A. Giatromanolaki Prognostic role of angiogenesis in non-small cell lung cancer Anticancer Res 21 2001 4373 4382
40. R.T. Poon, S.T. Fan, and J. Wong Clinical implications of circulating angiogenic factors in cancer patients J Clin Oncol 19 2001 1207 1225
41. S.J. Mandriota, P.A. Menoud, and M.S. Pepper Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells J Biol Chem 271 1996 11500 11505
42. Y. Tsurumi, T. Murohara, K. Krasinski, D. Chen, B. Witzenbichler, and M. Kearney Reciprocal relation between VEGF and NO in the regulation of endothelial integrity Nat Med 3 1997 879 886
43. E. Brylla, G. Tscheudschilsuren, A.N. Santos, K. Nieber, K. Spanel-Borowski, and G. Aust Differences between retinal and choroidal microvascular endothelial cells (MVECs) under normal and hypoxic conditions Exp Eye Res 77 2003 527 535
44. N. Ilan, A. Tucker, and J.A. Madri Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation? Lab Invest 83 2003 1105 1115
45. R.M.B. Loureiro, A.S.R. Maharaj, D. Dankort, W.J. Muller, and P.A. D'Amore ErbB2 Overexpression in mammary cells upregulates vascular endothelial growth factor through the core promoter Biochem Biophys Res Commun 326 2005 455 465
46. D.T. Shima, M. Kuroki, U. Deutsch, Y.S. Ng, A.P. Adamis, and P.A. D'Amore The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences J Biol Chem 271 1996 3877 3883
47. E. Berra, G. Pages, and J. Pouyssegur MAP kinases and hypoxia in the control of VEGF expression Cancer Metastasis Rev 19 2000 139 145
48. D.E. Richard, E. Berra, and J. Pouyssegur Angiogenesis: how a tumor adapts to hypoxia Biochem Biophys Res Commun 266 1999 718 722
49. 2 homeostasis by hypoxia-inducible factor 1 Annu Rev Cell Dev Biol 15 1999 551 578
50. S.C. Clifford, and E.R. Maher Von Hippel-Lindau disease: clinical and molecular perspectives Adv Cancer Res 82 2001 85 105
51. R. Ravi, B. Mookerjee, Z.M. Bhujwalla, C.H. Sutter, D. Artemov, and Q. Zeng Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha Genes Dev 14 2000 34 44
52. S.J. Welsh, W.T. Bellamy, M.M. Briehl, and G. Powis The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis Cancer Res 62 2002 5089 5095
53. Y. Liu, H. Christou, T. Morita, E. Laughner, G.L. Semenza, and S. Kourembanas Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer J Biol Chem 273 1998 15257 15262
54. H. Kimura, A. Weisz, Y. Kurashima, K. Hashimoto, T. Ogura, and F. D'Acquisto Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide Blood 95 2000 189 197
55. J.L. Shie, G. Wu, J. Wu, F.F. Liu, R.J. Laham, and P. Oettgen RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells J Biol Chem 279 2004 25010 25016
56. Y. Mizukami, J. Li, X. Zhang, M.A. Zimmer, O. Iliopoulos, and D.C. Chung Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer Cancer Res 64 2004 1765 1772
57. J. Fang, L. Yan, Y. Shing, and M.A. Moses HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis Cancer Res 61 2001 5731 5735
58. P. Carmeliet, Y. Dor, J.M. Herbert, D. Fukumura, K. Brusselmans, and M. Dewerchin Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Nature 394 1998 485 490
59. G. Hopfl, R.H. Wenger, U. Ziegler, T. Stallmach, O. Gardelle, and R. Achermann Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor Cancer Res 62 2002 2962 2970
60. E. Maltepe, B. Keith, A.M. Arsham, J.R. Brorson, and M.C. Simon The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia Biochem Biophys Res Commun 273 2000 231 238
61. E. Sivridis, A. Giatromanolaki, K.C. Gatter, A.L. Harris, and M.I. Koukourakis Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma Cancer 95 2002 1055 1063
62. M.I. Koukourakis, A. Giatromanolaki, E. Sivridis, C. Simopoulos, H. Turley, and K. Talks Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer Int J Radiat Oncol Biol Phys 53 2002 1192 1202
63. M.Y. Khalil, J.R. Grandis, and D.M. Shin Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer Expert Rev Anticancer Ther 3 2003 367 380
64. R. Kopp, E. Rothbauer, M. Ruge, H. Arnholdt, J. Spranger, and M. Muders Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options Recent Results Cancer Res 162 2003 115 132
65. C.K. Goldman, J. Kim, W.L. Wong, V. King, T. Brock, and G.Y. Gillespie Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology Mol Biol Cell 4 1993 121 133
66. A. Maity, N. Pore, J. Lee, D. Solomon, and D.M. O'Rourke Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3′-kinase and distinct from that induced by hypoxia Cancer Res 60 2000 5879 5886
67. P.P. Ongusaha, J.C. Kwak, A.J. Zwible, S. Macip, S. Higashiyama, and N. Taniguchi HB-EGF is a potent inducer of tumor growth and angiogenesis Cancer Res 64 2004 5283 5290
68. L. Yen, N. Benlimame, Z.R. Nie, D. Xiao, T. Wang, and A.E. Moustafa Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers Mol Biol Cell 13 2002 4029 4044
69. A.M. Petit, J. Rak, M.C. Hung, P. Rockwell, N. Goldstein, and B. Fendly Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors Am J Pathol 151 1997 1523 1530
70. E. Laughner, P. Taghavi, K. Chiles, P.C. Mahon, and G.L. Semenza HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol Cell Biol 21 2001 3995 4004
71. G. Finkenzeller, K. Weindel, W. Zimmermann, G. Westin, and D. Marme Activated Neu/ErbB-2 induces expression of the vascular endothelial growth factor gene by functional activation of the transcription factor Sp 1 Angiogenesis 7 2004 59 68
72. R. Bagheri-Yarmand, R.K. Vadlamudi, R.A. Wang, J. Mendelsohn, and R. Kumar Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis J Biol Chem 275 2000 39451 39457
73. L. Yen, X.L. You, A.E. Al Moustafa, G. Batist, N.E. Hynes, and S. Mader Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis Oncogene 19 2000 3460 3469
74. S. Xiong, R. Grijalva, L. Zhang, N.T. Nguyen, P.W. Pisters, and R.E. Pollock Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration Cancer Res 61 2001 1727 17232
75. Y.D. Jung, S.A. Ahmad, Y. Akagi, Y. Takahashi, W. Liu, and N. Reinmuth Role of the tumor microenvironment in mediating response to anti-angiogenic therapy Cancer Metastasis Rev 19 2000 147 157
76. C.F. Deroanne, A. Hajitou, C.M. Calberg-Bacq, B.V. Nusgens, and C.M. Lapiere Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression Cancer Res 57 1997 5590 5597
77. J. Gille, M. Khalik, V. Konig, and R. Kaufmann Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes J Invest Dermatol 111 1998 1160 1165
78. K. Reisinger, R. Kaufmann, and J. Gille Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription J Cell Sci 116 2003 225 238
79. A. Matsumori Roles of hepatocyte growth factor and mast cells in thrombosis and angiogenesis Cardiovasc Drugs Ther 18 2004 321 326
80. Y. Bian, V. Kaklamani, J. Reich, and B. Pasche TGF-beta signaling alterations in cancer Cancer Treat Res 115 2003 73 94
81. C. Nieder, J. Schlegel, N. Andratschke, R. Thamm, A.L. Grosu, and M. Molls The role of growth factors in central nervous system tumours Anticancer Res 23 2003 1681 1686
82. S.W. Beenken, and K.I. Bland Biomarkers for breast cancer Minerva Chir 57 2002 437 448
83. B. Xiong, L.L. Gong, F. Zhang, M.B. Hu, and H.Y. Yuan TGF beta1 expression and angiogenesis in colorectal cancer tissue World J Gastroenterol 8 2002 496 498
84. U. Renner, P. Lohrer, L. Schaaf, M. Feirer, K. Schmitt, and C. Onofri Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells Endocrinology 143 2002 3759 3765
85. Y. Sugano, K. Matsuzaki, Y. Tahashi, F. Furukawa, S. Mori, and H. Yamagata Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells Oncogene 22 2003 2309 2321
86. C. Benckert, S. Jonas, T. Cramer, Z. Von Marschall, G. Schafer, and M. Peters Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells Cancer Res 63 2003 1083 1092
87. K. Wagner, M. Peters, A. Scholz, C. Benckert, H.S. Ruderisch, and B. Wiedenmann Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells Gastroenterology 126 2004 1828 1843
88. C.C. Chua, R.C. Hamdy, and B.H. Chua Mechanism of transforming growth factor-beta1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells Biochim Biophys Acta 1497 2000 69 76
89. D.C. Darland, L.J. Massingham, S.R. Smith, E. Piek, M. Saint-Geniez, and P.A. D'Amore Pericyte production of cell-associated VEGF is differentiation- dependent and is associated with endothelial survival Dev Biol 264 2003 275 288
90. S. Ohta, M. Takeuchi, M. Deguchi, T. Tsuji, Y. Gahara, and K. Nagata A novel transcriptional factor with Ser/Thr kinase activity involved in the transforming growth factor (TGF)-beta signaling pathway Biochem J 350 Pt. 2 2000 395 404
91. S.P. Huang, M.S. Wu, C.T. Shun, H.P. Wang, M.T. Lin, and M.L. Kuo Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma J Biomed Sci 11 2004 517 527
92. M. Kawaguchi, M. Akagi, M.J. Gray, W. Liu, F. Fan, and L.M. Ellis Regulation of vascular endothelial growth factor expression in human gastric cancer cells by interleukin-1beta Surgery 136 2004 686 692
93. T. Cohen, D. Nahari, L.W. Cerem, G. Neufeld, and B.Z. Levi Interleukin 6 induces the expression of vascular endothelial growth factor J Biol Chem 271 1996 736 741
94. B.V. Diaz, M.C. Lenoir, A. Ladoux, C. Frelin, M. Demarchez, and S. Michel Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids J Biol Chem 275 2000 642 650
95. C. Patterson, M.A. Perrella, W.O. Endege, M. Yoshizumi, M.E. Lee, and E. Haber Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells J Clin Invest 98 1996 490 496
96. M. Ryuto, M. Ono, H. Izumi, S. Yoshida, H.A. Weich, and K. Kohno Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells: possible roles of SP-1 J Biol Chem 271 1996 28220 28228
97. S. Pal, K.P. Claffey, H.T. Cohen, and D. Mukhopadhyay Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta J Biol Chem 273 1998 26277 26280
98. S. Pal, K. Datta, R. Khosravi-Far, and D. Mukhopadhyay Role of protein kinase Czeta in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression J Biol Chem 276 2001 2395 2403
99. S.C. Shih, and K.P. Claffey Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L J Biol Chem 274 1999 1359 1365
100. N. Pore, S. Liu, H.K. Shu, B. Li, D. Haas-Kogan, and D. Stokoe Sp1 is involved in Akt-mediated induction of VEGF expression through a HIF-1-independent mechanism Mol Biol Cell 2004
101. M. Abdelrahim, R. Smith 3rd, R. Burghardt, and S. Safe Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells Cancer Res 64 2004 6740 6749
102. D. Wei, L. Wang, Y. He, H.Q. Xiong, J.L. Abbruzzese, and K. Xie Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity Cancer Res 64 2004 2030 2038
103. W. Ma, J. Tan, H. Matsumoto, B. Robert, D.R. Abrahamson, and S.K. Das Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus Mol Endocrinol 15 2001 1983 1992
104. J.L. Shifren, J.F. Tseng, C.J. Zaloudek, I.P. Ryan, Y.G. Meng, and N. Ferrara Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis J Clin Endocrinol Metab 81 1996 3112 3118
105. E.D. Albrecht, G.W. Aberdeen, A.L. Niklaus, J.S. Babischkin, D.L. Suresch, and G.J. Pepe Acute temporal regulation of vascular endothelial growth/permeability factor expression and endothelial morphology in the baboon endometrium by ovarian steroids J Clin Endocrinol Metab 88 2003 2844 2852
106. S.M. Hyder, and G.M. Stancel Regulation of VEGF in the reproductive tract by sex-steroid hormones Histol Histopathol 15 2000 325 334
107. J.K. Ruohola, E.M. Valve, M.J. Karkkainen, V. Joukov, K. Alitalo, and P.L. Harkonen Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells Mol Cell Endocrinol 149 1999 29 40
108. S.M. Hyder, L. Murthy, and G.M. Stancel Progestin regulation of vascular endothelial growth factor in human breast cancer cells Cancer Res 58 1998 392 395
109. M.D. Mueller, J.L. Vigne, E.A. Pritts, V. Chao, E. Dreher, and R.N. Taylor Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells Fertil Steril 79 2003 386 392
110. J. Wang, F. Luo, J.J. Lu, P.K. Chen, P. Liu, and W. Zheng VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors Int J Cancer 97 2002 163 167
111. H. Buteau-Lozano, M. Ancelin, B. Lardeux, J. Milanini, and M. Perrot-Applanat Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta Cancer Res 62 2002 4977 4984
112. S.M. Hyder, Z. Nawaz, C. Chiappetta, and G.M. Stancel Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor Cancer Res 60 2000 3183 3190
113. H. Kawai, H. Li, P. Chun, S. Avraham, and H.K. Avraham Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells Oncogene 21 2002 7730 7739
114. S. Haggstrom, I.F. Lissbrant, A. Bergh, and J.E. Damber Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats J Urol 161 1999 1620 1625
115. L. Bermont, F. Lamielle, S. Fauconnet, H. Esumi, A. Weisz, and G.L. Adessi Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells Int J Cancer 85 2000 117 123
116. L. Bermont, F. Lamielle, F. Lorchel, S. Fauconnet, H. Esumi, and A. Weisz Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells J Clin Endocrinol Metab 86 2001 363 368
117. L. Zhang, D. Yu, M. Hu, S. Xiong, A. Lang, and L.M. Ellis Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression Cancer Res 60 2000 3655 36561
118. B. Salimath, D. Marme, and G. Finkenzeller Expression of the vascular endothelial growth factor gene is inhibited by p73 Oncogene 19 2000 3470 3476
119. O. Lopez-Ocejo, A. Viloria-Petit, M. Bequet-Romero, D. Mukhopadhyay, J. Rak, and R.S. Kerbel Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53-independent manner Oncogene 19 2000 4611 4620
120. A. Arlt, and H. Schafer NFkappaB-dependent chemoresistance in solid tumors Int J Clin Pharmacol Ther 40 2002 336 347
121. S. Shukla, G.T. MacLennan, P. Fu, J. Patel, S.R. Marengo, and M.I. Resnick Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression Neoplasia 6 2004 390 400
122. J. Rak, J.L. Yu, G. Klement, and R.S. Kerbel Oncogenes and angiogenesis: signaling three-dimensional tumor growth J Investig Dermatol Symp Proc 5 2000 24 33
123. J. Milanini, F. Vinals, J. Pouyssegur, and G. Pages p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts J Biol Chem 273 1998 18165 18172
124. I.M. Oving, and H.C. Clevers Molecular causes of colon cancer Eur J Clin Invest 32 2002 448 457
125. V. Easwaran, S.H. Lee, L. Inge, L. Guo, C. Goldbeck, and E. Garrett β-Catenin regulates vascular endothelial growth factor expression in colon cancer Cancer Res 63 2003 3145 3153
126. X. Zhang, J.P. Gaspard, and D.C. Chung Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia Cancer Res 61 2001 6050 6054
127. S. Pal, K.P. Claffey, H.F. Dvorak, and D. Mukhopadhyay The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways J Biol Chem 272 1997 27509 27512
128. D. Mukhopadhyay, B. Knebelmann, H.T. Cohen, S. Ananth, and V.P. Sukhatme The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity Mol Cell Biol 17 1997 5629 5639
129. C.C. Lynch, and L.M. Matrisian Matrix metalloproteinases in tumor-host cell communication Differentiation 70 2002 561 573
130. T.H. Vu, J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, and D. Hanahan MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes Cell 93 1998 411 422
131. Y. Itoh, A. Ito, K. Iwata, K. Tanzawa, Y. Mori, and H. Nagase Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface J Biol Chem 273 1998 24360 24367
132. E.I. Deryugina, L. Soroceanu, and A.Y. Strongin Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis Cancer Res 62 2002 580 588
133. N.E. Sounni, C. Roghi, V. Chabottaux, M. Janssen, C. Munaut, and E. Maquoi Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases J Biol Chem 279 2004 13564 13574
134. L. Blavier, P. Henriet, S. Imren, and Y.A. Declerck Tissue inhibitors of matrix metalloproteinases in cancer Ann N Y Acad Sci 878 1999 108 119
135. A. Hajitou, N.E. Sounni, L. Devy, C. Grignet-Debrus, J.M. Lewalle, and H. Li Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis Cancer Res 61 2001 3450 3457
136. E.A. Sheta, M.A. Harding, M.R. Conaway, and D. Theodorescu Focal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factor J Natl Cancer Inst 92 2000 1065 1073
137. Y.S. Ng, R. Rohan, M.E. Sunday, D.E. Demello, and P.A. D'Amore Differential expression of VEGF isoforms in mouse during development and in the adult Dev Dyn 220 2001 112 121
138. K.A. Houck, N. Ferrara, J. Winer, G. Cachianes, B. Li, and D.W. Leung The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA Mol Endocrinol 5 1991 1806 1814
139. E. Tischer, R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, and J.C. Fiddes The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing J Biol Chem 266 1991 11947 11954
140. D.S. Charnock-Jones, A.M. Sharkey, J. Rajput-Williams, D. Burch, J.P. Schofield, and S.A. Fountain Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines Biol Reprod 48 1993 1120 1128
141. Z. Poltorak, T. Cohen, R. Sivan, Y. Kandelis, G. Spira, and I. Vlodavsky VEGF145: a secreted vascular endothelial growth factor isoform that binds to extracellular matrix J Biol Chem 272 1997 7151 7158
142. J.E. Park, G.A. Keller, and N. Ferrara The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF Mol Biol Cell 4 1993 1317 1326
143. P. Carmeliet, Y.-S. Ng, D. Nuyen, G. Theilmeier, K. Brusselmans, and I. Cornelissen Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 Nat Med 5 1999 495 502
144. D.T. Shima, U. Deutsch, and P.A. D'Amore Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability FEBS Lett 370 1995 203 208
145. J.A. Dibbens, D.L. Miller, A. Damert, W. Risau, M.A. Vadas, and G.J. Goodall Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements Mol Biol Cell 10 1999 907 919
146. L. Salomonsson, S. Pettersson, M.C. Englund, O. Wiklund, and B.G. Ohlsson Post-transcriptional regulation of VEGF expression by oxidized LDL in human macrophages Eur J Clin Invest 32 2002 767 774
147. F.C. White, A. Benehacene, J.S. Scheele, and M. Kamps VEGF mRNA is stabilized by ras and tyrosine kinase oncogenes, as well as by UV radiation: evidence for divergent stabilization pathways Growth Factors 14 1997 199 212
148. N.S. Levy, S. Chung, H. Furneaux, and A.P. Levy Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR J Biol Chem 273 1998 6417 6423
149. W.R. Paulding, and M.F. Czyzyk-Krzeska Hypoxia-induced regulation of mRNA stability Adv Exp Med Biol 475 2000 111 121
150. J.P. Crew, S. Fuggle, R. Bicknell, D.W. Cranston, A. de Benedetti, and A.L. Harris Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression Br J Cancer 82 2000 161 166
151. J.R. Graff, and S.G. Zimmer Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs Clin Exp Metastasis 20 2003 265 273
152. D.L. Miller, J.A. Dibbens, A. Damert, W. Risau, M.A. Vadas, and G.J. Goodall The vascular endothelial growth factor mRNA contains an internal ribosome entry site FEBS Lett 434 1998 417 420
153. I. Huez, S. Bornes, D. Bresson, L. Creancier, and H. Prats New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation Mol Endocrinol 15 2001 2197 2210
154. M. Meiron, R. Anunu, E.J. Scheinman, S. Hashmueli, and B.Z. Levi New isoforms of VEGF are translated from alternative initiation CUG codons located
155. A.C. Prats, and H. Prats Translational control of gene expression: role of IRESs and consequences for cell transformation and angiogenesis Prog Nucleic Acid Res Mol Biol 72 2002 367 413
156. J.W. Dennis, M. Granovsky, and C.E. Warren Protein glycosylation in development and disease Bioessays 21 1999 412 421
157. T.K. Yeo, D.R. Senger, H.F. Dvorak, L. Freter, and K.T. Yeo Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor) Biochem Biophys Res Commun 179 1991 1568 1575
158. D. Peretz, H. Gitay-Goren, M. Safran, N. Kimmel, D. Gospodarowicz, and G. Neufeld Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity Biochem Biophys Res Commun 182 1992 1340 1347
159. D.H. Walter, U. Hink, T. Asahara, E. Van Belle, J. Horowitz, and Y. Tsurumi The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation Lab Invest 74 1996 546 556
160. J. Plouet, F. Moro, S. Bertagnolli, N. Coldeboeuf, H. Mazarguil, and S. Clamens Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect J Biol Chem 272 1997 13390 13396
161. B.A. Keyt, L.T. Berleau, H.V. Nguyen, H. Chen, H. Heinsohn, and R. Vandlen The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency J Biol Chem 271 1996 7788 7795
162. K. Tachikawa, O. Schroder, G. Frey, S.P. Briggs, and T. Sera Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins Proc Natl Acad Sci USA 2004
163. T. Sanchez-Elsner, L.M. Botella, B. Velasco, A. Corbi, L. Attisano, and C. Bernabeu Synergistic cooperation between hypoxia and transforming growth factor-{beta} pathways on human vascular endothelial growth factor gene expression J Biol Chem 2 2001 2
164. J.A. Forsythe, B.H. Jiang, N.V. Iyer, F. Agani, S.W. Leung, and R.D. Koos Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Mol Cell Biol 16 1996 4604 4613